Navigation Links
Genzyme Announces Successful Completion of Study Investigating,Sevelamer Carbonate in Patients With Chronic Kidney Disease

CAMBRIDGE, Mass., April 16, 2007 /PRNewswire-FirstCall/ -- Genzyme Corp. announced today that a recently completed study of Renvela(TM) (sevelamer carbonate) achieved its primary endpoint, demonstrating a statistically significant reduction in serum phosphorus for hyperphosphatemic patients with chronic kidney disease who are not on dialysis.

Patients treated with Renvela also achieved a significant reduction in calcium-phosphorus product and in LDL cholesterol. The drug was well tolerated with a safety profile consistent with the clinical experience of patients on dialysis using Renagel(R) (sevelamer hydrochloride). The multi-center, single arm, open-label trial involved 49 patients at multiple study sites throughout Europe and Australia.

Full data will be presented at a future medical conference.

Renvela is a buffered form of Renagel, the most-prescribed phosphate binder in the United States. Like Renagel, Renvela is a calcium-free, metal- free, non-absorbed phosphate binder and will initially be available as 800mg tablets once approved.

The results announced today represent one portion of a comprehensive clinical program for sevelamer carbonate. Data showing the equivalence of sevelamer carbonate and sevelamer hydrochloride were presented last week at the spring clinical meeting of the National Kidney Foundation. In addition, enrollment is complete in two studies comparing a powder form of sevelamer carbonate to Renagel tablets dosed three times per day, including one study in which the powder form is dosed three times per day, and one in which it is dosed once per day.

A New Drug Application for Renvela is currently under review by the US Food and Drug Administration for the control of serum phosphorus in patients with chronic kidney disease on dialysis.

About Renagel

Renagel controls serum phosphorus in patients with CKD on hemodialysis. Controlling serum ph
'"/>




Page: 1 2 3

Related medicine technology :

1. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
2. Genzyme Announces Results of Clinical Trial of Hylastan
3. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
4. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
5. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:7/28/2015)... -- Codman Neuro*, part of DePuy Synthes Companies of ... embolic coils for the treatment of brain aneurysms, supported ... stability and provide an optimized detachment zone for coils ... Society of NeuroInterventional Surgery (SNIS) 12 th Annual ... finishing coils used during a minimally invasive endovascular procedure ...
(Date:7/28/2015)... , July 28, 2015  Insulet Corporation (NASDAQ: ... technology with its OmniPod ® Insulin Management System, ... been appointed to Insulet,s Board of Directors. ... healthcare experience to the Insulet Board. She currently serves ... Joslin Diabetes Center, the world,s largest diabetes research center, ...
(Date:7/28/2015)... Colo. , July 28, 2015   ... the "Company"), a provider of  advanced veterinary diagnostic ... the availability of the new Element i ® ... testing and screening for key health concerns, including ... Element i is a compact bench top analyzer ...
Breaking Medicine Technology:Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 2Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 3Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 4Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 2Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 3
... Leading health sciences publisher makes key ... UN developing world research access program ... information products and services, today announced that it is ... , a public-private partnership working to achieve the UN,s ...
... (NASDAQ: LMNX ) today announced that it expects ... on Tuesday, November 1, 2011.  A press release announcing ... of trading. (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... the operating highlights and financial results for the third quarter ...
Cached Medicine Technology:Elsevier Offers 950 New Health Titles to Research4Life 2Elsevier Offers 950 New Health Titles to Research4Life 3Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011 2Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011 3
(Date:7/29/2015)... IL (PRWEB) , ... July 29, 2015 , ... People ... benefit from two new products on Mercola.com: a vertical “garden tower” and enhanced mineral ... can be squeezed into small corners on a porch, balcony, or rooftop – can ...
(Date:7/29/2015)... ... July 29, 2015 , ... One of the world’s leading ... the potentially lifesaving impact of removing aluminum from Alzheimer’s disease patients, announced the ... is based on a successful pilot study published in The Journal of Alzheimer’s ...
(Date:7/29/2015)... ... July 29, 2015 , ... EndoMune Advanced ... chewable version of its EndoMune Jr. probiotic supplement for children ages 3-8. , ... children can enjoy to maintain a healthy balance of beneficial gut bacteria,” said ...
(Date:7/29/2015)... ... ... One may not expect to encounter a kickball game or the sound ... happening on the campus of Piedmont Crossing , a local 60-acre retirement community. ... , a five-star childcare center which operates on the same campus. As many as ...
(Date:7/29/2015)... ... July 29, 2015 , ... Nature’s Artisan, a new holistic ... gourmet flavors. , Nature’s Artisan was founded by Tina Yarandi, who came up with ... UCLA School of Dentistry. Tina was amazed when she learned about the incredible dental ...
Breaking Medicine News(10 mins):Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 2Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 4Health News:Discover a New Take on Oral Care with Nature’s Artisan Gourmet Mouthwashes 2
... and interactions between noncoding genes play a much greater ... research, published by Cell Press in the September issue ... identifying tumor-specific signatures associated with diagnosis, prognosis, and treatment ... oncogenes or tumor suppressor genes. More recently, a large ...
... implanted in the skull that detects oncoming seizures, then delivers ... is under study at the Medical College of Georgia. , ... to determine if the neurostimulator device can help patients whose ... constantly monitors electrical activity of the brain, gets accustomed to ...
... LINDA, Calif., Sept. 10 Loma Linda ... Adventist institution located,in Southern California, has chosen ... referrals and outbound reminder calls for its ... physician referrals for breast care, psychology, urology,gynecology, ...
... entries reveal wellness trends of on-staff pharmacists, ... a focus on healthy aging, CHICAGO, Sept. ... the third-annual Health at Work Award: Sprint; Erie ... Library District. Winners,were selected based on their wellness ...
... Merger and Manage Company Company Announces ... 10 Arrow International,Inc. (Nasdaq: ARRO ), a ... critical and cardiac care, reported that Glass,Lewis & Co., ... to,approve Arrow,s planned $45.50 merger with Teleflex Incorporated (NYSE:,TFX) ...
... Robbins & Myers, Inc.,(NYSE: RBN ) announced ... year results for 2007, which ended August 31, 2007, ... live webcast of the conference call,will be held at ... Robbins & Myers will be Peter C. Wallace, President ...
Cached Medicine News:Health News:Altered expression of ultraconserved noncoding RNAs linked to human leukemias and carcinomas 2Health News:Implantable device designed to detect, stop seizures under study at MCG 2Health News:Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Women's Services Programs and Departments 2Health News:ComPsych(R) Corp. Announces Health at Work(SM) Award Winners: Sprint, Erie Insurance, City of Naperville and Green Hills Public Library 2Health News:Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting 2Health News:Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting 3
... 420 CPAP System is the smallest and ... on the market. It is designed to ... lifestyles while complying with therapy. The GoodKnight ... of date/time usage data. It also detects ...
Micro-hematocrit tubes available in multiple sizes and additives for a wide range of capillary blood collection....
... VH IVUS technology uses advanced spectral ... of ultrasound images and provide detailed ... patient's atherosclerotic plaques. The colorized VH ... fibrous, fibro-fatty, dense calcium, and necrotic ...
... the GE Innova 2100IQ: See the finest ... Place interventional devices. Its all enabled by ... that helps deliver excellent image quality and ... family systems installed worldwide, more physicians rely ...
Medicine Products: